WeVote
Log In

Bill

Bill

HB 3561

INS CD-EGG & PEANUT ALLERGY

104th Regular Session Introduced by Dee Avelar

Illinois bill requiring insurers to cover epinephrine auto-injectors for egg and peanut allergies without prior authorization to ensure emergency access.

Rule 19(a) / Re-referred to Rules Committee
0
WeVote Research Nonpartisan
Bill Summary · HB 3561

Legislative bill overview

HB 3561 requires Illinois insurance companies to cover epinephrine auto-injectors (EpiPens) and related emergency allergy medications for patients with egg and peanut allergies without prior authorization requirements. The bill mandates that these life-saving devices be treated as essential emergency medications under insurance plans.

Why is this important

Severe allergic reactions to eggs and peanuts can be fatal within minutes, and access to epinephrine auto-injectors is often the difference between life and death. Insurance barriers like prior authorization delays can prevent patients from obtaining these devices quickly, particularly affecting children and low-income families who may rely on insurance coverage.

Potential points of contention

  • Insurance cost concerns: Insurers may argue this mandates coverage without cost controls and could increase premiums for all policyholders
  • Scope limitations: The bill specifically targets egg and peanut allergies; stakeholders may question why other severe allergies aren't included or why this distinction exists
  • Prior authorization rationale: Some insurers use prior authorization to prevent misuse; removing it entirely may face pushback from those who believe it prevents unnecessary prescriptions

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.